Samarth Kulkarni - 15 Oct 2021 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Chief Executive Officer, Director
Signature: /s/ Michael Esposito, attorney-in-fact
Issuer symbol: CRSP
Transactions as of: 15 Oct 2021
Net transactions value: +$59,730
Form type: 4
Filing time: 18 Oct 2021, 20:00:22 UTC
Previous filing: 03 Sep 2021
Next filing: 03 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRSP	Common Shares	Options Exercise	$59,730	+33,000	+18%	$1.81^*	219,932	15 Oct 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Stock Option (Right to Buy)	Award	$0	+43,000		$0.000000	43,000	15 Oct 2021	Common Shares	43,000	$97.00	Direct	F1
transaction	CRSP	Stock Option (Right to Buy)	Options Exercise	$0	-33,000	-30%	$0.000000	75,983	15 Oct 2021	Common Shares	33,000	$1.81	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on October 15, 2021 with respect to 43,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 15, 2021.
F2	This option was granted on September 10, 2015 with respect to 321,712 Common Shares with 120,640 of the shares vested on August 1, 2016, the first anniversary of employment commencement, and the remainder vested in equal 36 monthly installments thereafter.